Loop-to-helix transition in the structure of multidrug regulator AcrR at the entrance of the drug-binding cavity

Babu A. Manjasetty, Andrei S. Halavaty, Chi-Hao Luan, Jerzy Osipiuk, Rory Mulligan, Keehwan Kwon, Wayne F. Anderson, Andrzej Joachimiak

    Research output: Contribution to journalArticlepeer-review

    8 Scopus citations


    Multidrug transcription regulator AcrR from Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 belongs to the tetracycline repressor family, one of the largest groups of bacterial transcription factors. The crystal structure of dimeric AcrR was determined and refined to 1.56 Å resolution. The tertiary and quaternary structures of AcrR are similar to those of its homologs. The multidrug binding site was identified based on structural alignment with homologous proteins and has a di(hydroxyethyl)ether molecule bound. Residues from helices α4 and α7 shape the entry into this binding site. The structure of AcrR reveals that the extended helical conformation of helix α4 is stabilized by the hydrogen bond between Glu67 (helix α4) and Gln130 (helix α7). Based on the structural comparison with the closest homolog structure, the Escherichia coli AcrR, we propose that this hydrogen bond is responsible for control of the loop-to-helix transition within helix α4. This local conformational switch of helix α4 may be a key step in accessing the multidrug binding site and securing ligands at the binding site. Solution small-molecule binding studies suggest that AcrR binds ligands with their core chemical structure resembling the tetracyclic ring of cholesterol.
    Original languageEnglish
    JournalJournal of Structural Biology
    VolumeAvailable online
    StatePublished - 2016


    Dive into the research topics of 'Loop-to-helix transition in the structure of multidrug regulator AcrR at the entrance of the drug-binding cavity'. Together they form a unique fingerprint.

    Cite this